BioSpace News Archive

Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug development in rare respiratory diseases, announced mechanistic preclinical pharmacodynamic and Phase 1 data supporting once-daily dosing of rodatristat ethyl for the treatment of pulmonary arterial hypertension (PAH).

MYOS CEO Joseph Mannello to Speak at the ‘Innovation Showcase’ on November 8 at 12:30pm ET

Webcast scheduled for Wednesday, November 6th at 11:30 a.m. Eastern Time

National Institutes of Health awards contract for CRISPR-based disease modeling in iPS cell lines associated with Alzheimer’s, Stem cell pioneer Bill Skarnes joins advisory board

Company developing commercial strategies and operational capabilities to support future product launches as investigational gene therapies advance through clinic

12-Month Clinical Results of Micro-Invasive Canal Viscodilation in Combination with Cataract Surgery on Over 100 Consecutive Eyes Demonstrates Long-Term IOP and Medication Reduction in Mild to Moderate POAG

ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its third quarter 2019 earnings release and conference call.

ADMA Biologics, Inc. announced that it has been named Company of the Year by BioFlorida, in recognition of ADMA’s significant achievements over the past year.

Longtime correctional healthcare executive Teri Gregory has joined Corizon Health as vice president of operations for the state of Kansas, the company announced.

miRagen Therapeutics, Inc., a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on microRNAs, will host a conference call and webcast on Thursday, November 7th, at 4:30 p.m.